Why the study?
Pulmonary arterial hypertension remains a major cause of mortality, and managing acute right heart failure in the intensive care unit presents multifaceted challenges requiring multidisciplinary strategies.
This review summarizes the multifaceted intensive care management strategies, including hemodynamic monitoring and targeted therapies, for adult patients with pulmonary arterial hypertension presenting with acute decompensated right heart failure.
Does not alter ICU practice for PAH-related right heart failure; leaves open need for prospective trials to validate strategies.
Despite substantial advancements in diagnosis and specific medical therapy in pulmonary arterial hypertension patients' management, this condition continues to represent a major cause of mortality worldwide. In pulmonary arterial hypertension, the continuous increase of pulmonary vascular resistance and rapid development of right heart failure determine a poor prognosis. Against targeted therapy, patients inexorable deteriorate over time. Pulmonary arterial hypertension patients with acute right heart failure who need intensive care unit admission present a complexity of the disease pathophysiology. Intensive care management challenges are multifaceted. Awareness of algorithms of right-sided heart failure monitoring in intensive care units, targeted pulmonary hypertension therapies, and recognition of precipitating factors, hemodynamic instability and progressive multisystem organ failure requires a multidisciplinary pulmonary hypertension team. This paper summarizes the management strategies of acute right-sided heart failure in pulmonary arterial hypertension adult cases based on recently available data.
No takes yet. Share an insight, caveat, or question.
Ţilea et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: